Tofacitinib: Phase III data

Pfizer Inc. (NYSE:PFE), New York, N.Y. Product: Tofacitinib ( Jaquinus, Xeljanz) Business: Autoimmune Molecular target: Janus kinase-3 (JAK-3); Janus kinase-1 (JAK-1) Description: Oral pan- Janus k...